Profusa (PFSA) Non-Current Deferred Tax Liability (2022 - 2023)
Profusa (PFSA) posted quarterly Non-Current Deferred Tax Liability of $13661.0 for Q4 2023, down 63.02% year-over-year from $36940.0 in Q4 2022, and down 98.92% quarter-over-quarter from $1.3 million in Q3 2023.
Profusa (PFSA) Non-Current Deferred Tax Liability (2022 - 2023) Analysis & Trends
Profusa's Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $13661.0 for Q4 2023.
- In Q4 2023, Non-Current Deferred Tax Liability fell 63.02% year-over-year to $13661.0; the TTM figure through Dec 2023 stood at $13661.0 (down 63.02% YoY), while the FY2023 annual figure was $13661.0, down 63.02% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2023 stood at $13661.0, down from $1.3 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $1.3 million in Q3 2023, with the low at $13661.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Profusa | 92,085.85 | -282,914.15 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 13,661.00 |
| Dec 31, 2023 | 13,661.00 |
| Sep 30, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 735,048.00 |
| Jun 30, 2023 | 735,048.00 |
| Dec 31, 2022 | 36,940.00 |
| Dec 31, 2022 | 36,940.00 |